首页> 外国专利> Derivatives of arilciclohexileteres 5,6 dihydro - 4 - 2,3,5,10 - B - Chemicals - benzo e Azulene, Pharmaceutical compositions containing Same, Preparation Process and Use thereof in sexual Dysfunctions and disorders of the CNS, among other pathologies.

Derivatives of arilciclohexileteres 5,6 dihydro - 4 - 2,3,5,10 - B - Chemicals - benzo e Azulene, Pharmaceutical compositions containing Same, Preparation Process and Use thereof in sexual Dysfunctions and disorders of the CNS, among other pathologies.

机译:环己基环戊二烯5,6-二氢-4-2,3,5,10-B-化学品-苯并[e]氮杂苯的衍生物,包含相同成分的药物组合物,其制备方法及其在中枢神经系统性功能障碍和疾病中的用途以及其他病理。

摘要

The compounds of the invention act as modulators of The Pathway of receptor and Receptor Antagonists, in particular as the route; The Invention further refers to its acquisition, Pharmaceutical compositions containing them and their use as medicines.The active compounds of the present Invention are useful as therapeutic agents acting at Peripheral and central level in Pathological States such as dysmenorrhea, male or Female Sexual Dysfunction, hypertension, Chronic Heart Failure, inappropriate secretion of vasopr Resin, Liver cirrhosis, nephrotic syndrome, anxiety, Depressive Disorders, obsessive-compulsive Disorder,Autistic Spectrum Disorders, Schizophrenia and Aggressive Behaviour.Claim 1: The Compound of the General formula (1) wherein R1 is aryl or heteroaryl, without replacing or replaced by one or more substituents selected Independence between alkyl; R2 is H, or C1 - 12, without replacing replaced by one or more Oh, halogen, alkoxy or cyano C1 - 12 - Q - (CH2) IN RA, the ra is phenyl or heteroaryl 5 or 6 layersEach of them is no substitute or substituted by one or more substituents selected Independence between a - (CH2) rnririi, - C (o) - alkyl alkyl C1 C1 - 12, - 12 without replacing or is replaced by one or more Oh, halogen, alkoxy or cyano C1 - 12, - C (o) (CH2) (QOC) - C1 - 12 alkyl, - C (o) - (CH2) Qnririi, - C (o) or alkyl C1 - 12, the rent is no substitute or substituted by one or more Oh, halogenCyano or alcosi C1 - 12, - S (o) 2 - alkyl of C1 - 12, - S (o) 2nririi, RI and RII with Independence among c1-12 is H, alkyl, or with Nitrogen, which together form a heterocicloalquilo 3 to 7 links containing one or dods heteroatoms selected from N, o and S, Said heterocicloalqui Is no substitute or substituted by one or more substituents elected for Independence between BQ is the Number 1, 2, 3 or 4, R is the Number 2, 3 or 4 is Halogen, alkyl, cyano, Oh, haloalquilo C1 C1 - 7, 7, 7 haloalcoxi alkoxy C1, C1 and C1 - 7 - 7 Hydroxy alkyl, B is oxo Halogen, oh alkyl or alkoxy C1 C1 - 7 - 7, R3 is cl or F, or a pharmaceutically acceptable Salt thereof.
机译:本发明的化合物充当受体和受体拮抗剂的途径的调节剂,特别是作为途径。本发明还涉及其获得,含有它们的药物组合物及其作为药物的用途。本发明的活性化合物可用作在病理状态如痛经,男性或女性性功能障碍,高血压中在外周和中枢水平起作用的治疗剂。 ,慢性心力衰竭,血管树脂的不适当分泌,肝硬化,肾病综合征,焦虑症,抑郁症,强迫症,自闭症,精神分裂症和攻击行为。要求1:通式为(1)的化合物,其中R1是芳基或杂芳基,没有被取代或被一个或多个选择的取代基取代,烷基之间独立; R2为H或C1-12,未被一个或多个哦,卤素,烷氧基或氰基取代,C1-12-Q-(CH2)IN RA中,ra为苯基或杂芳基5或6层,每一个均无取代基或被一个或多个选择的取代基取代-(CH2)甲基,-C(o)-烷基烷基C1-12--12之间的独立性而不被或被一个或多个Oh,卤素,烷氧基或氰基C1-取代12,-C(o)(CH2)(QOC)-C1-12烷基,-C(o)-(CH2)Qnririi,-C(o)或C1-12烷基,房租不可替代或被一个取代卤素,氰基或醇铝C1-12,-C1-12的S(o)2-烷基,c1-12之间具有独立性的S(o)2nririi,RI和RII为H,烷基或氮。一起形成包含3个或7个选自N,o和S的杂原子的杂环烷基连接基,所述杂环烷基不被取代或被一个或多个取代基所取代,BQ之间的独立性为1、2、3或4,R是2、3或4是H烷基,氰基,氰基,卤素,卤代alquilo C1 C1-7、7、7卤代烷氧基烷氧基C1,C1和C1-7-7羟基烷基,B是氧代卤素,烷基或烷氧基C1 C1-7-7,R3是cl或F,或其药学上可接受的盐。

著录项

  • 公开/公告号AR074409A1

    专利类型

  • 公开/公告日2011-01-12

    原文格式PDF

  • 申请/专利权人 F. HOFFMANN - LA ROCHE AG.;

    申请/专利号AR2009P104565

  • 发明设计人 SCHNIDER PATRICK;

    申请日2009-11-26

  • 分类号C07D487/04;A61K31/5517;A61P5/24;A61P15/10;A61P15/12;A61P25/00;

  • 国家 AR

  • 入库时间 2022-08-21 18:07:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号